ImCheck’s ICT01 receives FDA ODD for treatment of acute myeloid leukemia
Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials
Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
A triple-action Formula for comprehensive respiratory relief
Subscribe To Our Newsletter & Stay Updated